Results 211 to 220 of about 4,500,819 (268)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Reply to: an assessment of the cytochrome P450 2-hydroxyisoflavanone synthase (2-HIS) crystal structure. [PDF]

Commun Biol
Wang X, Pan H, Sagurthi SR, Dixon RA.
europepmc   +1 more source

GPR182 and the reframing of lacteal chylomicron uptake. [PDF]

J Clin Invest
Yu L.
europepmc   +1 more source

A Hybrid ISSA-XGBoost Model for Predicting Wellbore Leakage. [PDF]

Sensors (Basel)
Bai K, Chen J, Yin S, Wei C, Yan Y, Liu J.   +5 more
europepmc   +1 more source

DG-LSTM-SA model: A deep gated LSTM network with self-attention mechanism for power generation and load forecasting. [PDF]

PLoS One
Sun G, Zhao Y, Li J, Cui J, Qi X.
europepmc   +1 more source

Statement of Retraction: Involvement of long non-coding RNA ZNF503 antisense RNA 1 in diabetic retinopathy and its possible underlying mechanism. [PDF]

Bioengineered
europepmc   +1 more source

Passive adaptive grippers: a mini-review. [PDF]

Front Robot AI
Chan MC, Scharff RBN.
europepmc   +1 more source